Viswanath, Satish E. http://orcid.org/0000-0003-4550-8337
Chirra, Prathyush V.
Yim, Michael C.
Rofsky, Neil M.
Purysko, Andrei S.
Rosen, Mark A.
Bloch, B Nicolas
Madabhushi, Anant
Funding for this research was provided by:
National Institutes of Health (1U24CA199374-01)
National Institutes of Health (R01CA202752-01A1)
National Institutes of Health (R01CA208236-01A1)
National Institutes of Health (R01CA216579-01A1)
National Institutes of Health (R01CA220581-01A1)
National Center for Research Resources (1 C06 RR12463-01)
DOD/CDMRP (PC120857)
DOD/CDMRP (LC130463)
DOD/CDMRP (W81XWH-16-1-0329)
National Institute of Diabetes and Digestive and Kidney Diseases (1P30DK097948 DDRCC Pilot/Feasibility Award)
National Institute of Biomedical Imaging and Bioengineering (T32EB00750912 CWRU Interdisciplinary Biomedical Imaging Fellowship)
Article History
Received: 11 July 2018
Accepted: 10 January 2019
First Online: 28 February 2019
Ethics approval and consent to participate
: The patient MRI datasets used in this study were retrospectively acquired from independent patient cohorts curated from different sites, where the data was initially acquired under written informed consent at each collecting institution. All 3 datasets comprised de-identified MRI data together with expert annotations of tumor extent, which were provided to the authors through the IRB protocol # 02-13-42C approved by the University Hospitals of Cleveland Institutional Review Board. Data analysis was waived review and consent by the IRB board, as all data was being analyzed retrospectively, after de-identification.
: Not applicable (see Ethics Statement).
: AM is an equity holder in Elucid Bioimaging and Inspirata Inc. He is also a scientific advisory consultant for Inspirata Inc. In addition he currently serves as a scientific advisory board member for Inspirata Inc, Astrazeneca, and Merck. He also has sponsored research agreements with Philips and Inspirata Inc. His technology has been licensed to Elucid Bioimaging and Inspirata Inc. He is also involved in a NIH U24 grant with PathCore Inc and 3 different R01 grants with Inspirata Inc. SV is a scientific advisory board member and equity holder in Virbio, Inc and a member of the Editorial Board of BMC Medical Imaging.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.